Get the Weekly Intelligence Brief — top committee picks every Sunday.
MDT · NYSE · STOCK

Medtronic (MDT) Stock Analysis

Healthcare Updated October 10, 2026
$88.48
52W $73.31 – $106.33
53/100
$113.26B
21.6
0.57
AI Committee Verdict
Watch
53/100
Conviction: Moderate · 60% agreement · 5 analysts
+3.4%
-1.1%
3.15:1
Moderate

Is MDT Bullish or Bearish?

Mixed. Innellis AI committee rates Medtronic plc (MDT) Watch with a composite score of 53/100 , based on 5 analysts with 60% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +6.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -13.17 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Dividend yield of 3.5% pays you to wait — Value
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
53/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 77%
of 192 Healthcare peers
Value Analyst neutral
58 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 3.5% pays you to wait
Growth Analyst bearish
38 / 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 53.2 to 53.2.

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
52.4
Neutral
MACD Histogram
-0.170
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Support
$87.52
Resistance
$91.49
Bollinger %B
0.42
Inside Bands
Price vs Moving Averages
EMA 9
$87.65 Above
EMA 21
$88.70 Below
EMA 50
$88.67 Below
EMA 200
$88.04 Above

Fundamental Analysis

Valuation
76
Growth
56
Profitability
67
Financial Health
98
Cash Flow
70
Valuation
P/E Ratio 21.6×
P/B Ratio 2.25×
PEG Ratio 1.71
Dividend Yield 3.23%
52W High $106.33
52W Low $73.31
Quality & Growth
ROE 970.4%
ROA 516.0%
Gross Margin 6669.1%
Operating Margin 1807.6%
Revenue Growth YoY —
Debt / Equity 0.56
AI Fundamental Assessment
P/E ratio of 21.6 (inexpensive relative to a 15-40x range); Price-to-book of 2.3x; PEG ratio of 1.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 9.7%; Return on assets of 5.2%; Net margin of 13.9%; Gross margin of 66.7%; Current ratio of 2.07 (healthy short-term liquidity); Debt-to-equity of 0.56; Free cash flow per share is positive (4.79); Most recent quarter beat estimates by 3.4%; EPS growth decelerating (+14.0% -> -6.5% QoQ); Average YoY EPS growth of 15.1%; Analyst estimates rising over recent quarters
Get the Full MDT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime